NSCMID 2023 Meeting Scientific Programme

Örebro Sweden 21 - 24 September 2023

 

Pre course - Omics approaches for Clinical Microbiology and Infectious Diseases
In association to the NSCMID meeting at Örebro Sweden 2023 there was a pre course on Omics.

The course was arranged as a course for PhD students but was also open for participation by other interested participants of the NSCMID meeting.

The course was arranged by Örebro University and the NSCMID and took place on September 20-21, 2023 at Campus USÖ, Örebro University, Sweden.

 

Thursday 21 September

09:00 - 12:30 Registration open

11:30 - 12:30 Lunch

12:30 - 12:40 Opening of NSCMID 2023

 

12:40 - 13:40 Symposium 1
Neisseria meningitdis - similar yet so different. Experiences from the Nordic countries

Chair: Paula Mölling

Sara Sofie Wiksmoen Watle, NO, Epidemiology of invasive meningococcal disease and carriage

Steen Hoffmann, DK, Meningococcal vaccine policies

13:40 - 13:45 Short break

 

13:45 - 15:05 Symposium 2

Precision medicine in severe infections - are we ready?

Chair: Sara Cajander

Adam Linder, SE, Phenotyping of sepsis using advanced masspectrometry

Jan Kristian Damas, NO, Including genetic and clinical data in individual risk prediction of severe infections

Aleksander Rygh Holten, NO, The utility of biomarkers in early sepsis management

15:05 - 15:35 Coffee in the exhibition

 

15:35 - 16:50 Symposium 3
Respiratory infections in children - complications and progress. In collaboration with NORDPID

Chair: Terho Heikkinen

AnnaCarin Horne, SE, MIS in covid-19 and beyond

Mette Holm, DK, Epidemiology, age distribution and clinical presentation of RSV

Terho Heikkinen, Fl, Management and prevention of RSV in children

 

16:50 - 17:40 Honorary lecture
Chair: Martin Sundqvist

Magnus Gisslén, SE, Covid-19 and HIV/AIDS: Assessing Their Roles in the Spectrum of Pandemics

Welcome reception at Örebro Castle
Local foods and music

Friday 22 September
 
Sponsored Symposium by Astra Zeneca
Chair: Sara Lind Enoksson, AstraZeneca

Antibody-mediated protection against diverse pathogens, Daniel Sheward, SE

 

08:30 - 09:30 Pro/Con discussion

Combination treatment in severe bacterial infections

Chair: Sara Cajander.

Pro: Mia Furebring, SE, Combination treatment is the way to go!

Con: Pontus Naucler, SE, Combination treatment does not add!

09:30 - 10:00    Coffee in the exhibition

 

10:00 - 12:00 Symposium 4
How to use new and old antibiotics in infections caused by MDR Enterobacterales and Pseudomonas. In collaboration with NORDICAST

Chair: Edvin lngberg and Kristian Tonby

Christian Giske, SE, New and old Antibiotics

Thomas Tangden, SE, Recommendations regarding the use of these drugs

Erika Matuschek, SE, How to perform AST for these agents

Interactive session with clincial cases

 

12:00 - 12:30 Lunch in the exhibition

12:30 - 13:45 Poster Exhibition with 3 selected poster presentations

 

13:45 - 14:30    Sponsored Symposium by Shionogi
Chair: Asko Jarvinen

Rafael Canton, Clinical Microbiology Department, Servicio de Microbiologfa. Hospital Universitario Ramon y Cajal-lRYCIS

"Evolving landscape of Gram-negative resistance and the promises of a siderophore cephalosporin"

Luke Moore, Imperial College London, Faculty of Medicine, Department of Infectious Disease Honorary dinical Senior Lecturer

"Real world evidences for Cefiderocol across Europe"

14:30 - 15:00 Coffee in the exhibition

15:00 - 16:20 Symposium 5
Fecal microbiota transplantation - the use, efficacy and cost effectiveness

Chair: Martin Sundqvist

Ed J. Kuijper, NL, FMT in the treatment of C.difficile

Julia König, SE, FMT in Irritable Bowel Syndrome

Lena Serrander, SE, Practical and regulatory aspects of FMT
 

Saturday 23 September
 
08:00 - 08:30 NSCMID General Assembly

08:30 - 09:00 Sponsored Symposium by Tillotts Pharma
Chair: Cecilia Magnusson

A critical approach to the ESCMID C. difficile guideline
Professor Benoit Guery, Centre Hospitalier Universitaire Vaudois (CHUV) Lausanne, Switzerland

09:00- 09:10 Short break

09:10 - 10:40 Symposium 7
New insights into Implant-associated infections

Chair: Bo Soderquist

Annelies Zinkernagel, CH, Staphylococcal host adaptation and evolution

Holger Bruggerman, DK, Infection or contamination? Implant-associated infections associated with Cutibacteria

Marc Stegger, DK, Origin and selection of S. epidermidis causing prosthetic joint infections

10:40 - 11:10 Coffee in the exhibition

11:10 - 12:10 Symposium 8
Elimination of Hepatitis C in the Nordic Countries

Chair: Ann-Safi Duberg

Nina Weis, DK, Towards HCV elimination in Denmark

Olav Dalgard, NO, Has HCV infection been eliminated in Norway?

12:10 - 13:00 Lunch in the exhibition

13:00 - 14:20 Invited Young Scientists
Chairs: Martin Sundqvist and Anders Johansson

Tryggvi Bragason Hordur, IS
Mortality from Invasive Pneumococcal Disease over a 40-Year Period: A Population-Based Study

Ahmad I AI-Mustapha, Fl
Population-level prediction of Methicillin Resistant Staphylococcus Aureus in Finland: a culture-based wastewater surveillance approach

Karolina Liljedahl Prytz, SE
Beta-lactam concentrationsin patients with sepsis treated in the Intensive Care Unit

Srijana Bastakoti, NO
Coculturing with Streptococcus anginosus alters Staphylococcus aureus transcriptome when exposed to tonsillar cells

Morten Eneberg Nielsen, DK
Rapid bloodstream infection diagnostics enabled by Nanopore plasma metagenomic DNA sequencing

14:20 - 14:25 Short break

 

14:25 - 15:10 Sponsored Symposium by Pfizer

The role of T cell immunity against respiratory viral infections, Markus Bruggert, SE

15:10 - 15:40  Coffee in the exhibition

15:40-17:10 Symposium 9
Metagenomics in infection, inflammatory disease and the environment

Chair: Paula Mölling

David Eyre, UK, Clinical Metagenomics in infectious diseases - where are we today?

Jonas Halfvarson, SE, Towards precision medicine in IBD

Johan Bengtsson-Palme, SE, Tracking AMR in the environment

 

19.00 - 23:00 Congress Dinner at Conventum Congress Center

 

Sunday 24 September

08:45 - 10:15 Symposium 10

Tick Borne Encephalitis - prevention and epidemiology

In collaboration with NSCMID Tick Borne Diseases Group

Chair Magnus Johansson

Robert Steffen, CH, Duration of protection by Tick Borne Encephalitis (TBE) vaccines: Pursuing the discussion

Helena Hervius Askling, SE, TBE-vaccines: what is the best priming-schedule and what about vaccine-failures?

Åshild Andreassen, No, TBEV in Norway and Scandinavia in relation to climate change

10:15 - 10:40 Coffee in the exhibition

 

10:40 - 12:00 Hot Topics

Theme: Antibiotics and rapid susceptibility testing

Chair Martin Sundqvist

Kaisu Rantakokko-Jalava, FI, Rapid AST directly from positive blood cultures

Valtyr Thors, IS, Post pandemic surge of scarlet fewer and severe infections caused by S.pyogenes

Kristoffer Strålin, SE, Corticosteroids in severe community aquired pneumonia

Welcome to NSCMID 2024

12.10 - Take away lunch